Article and Video CATEGORIES

Cancer Journey

Search By

Carlea has over 20 years of experience in nonprofit management and health advocacy. In October 2013, she joined The Global Resource for Advancing Cancer Education as its first executive director. She directs its growth in revenue, outreach and programs.

30 Days of Clinical Trials, Victories, and Gratitude

With the Thanksgiving holiday in November, the month has become synonymous with gratitude in the U.S. November is also Lung Cancer Awareness Month; an initiative started in 1995 to increase knowledge of the disease. 

GRACE decided to combine the two ideas. For the next month, we will post videos, images and blog posts where a patient, caregiver, or doctor highlights a currently- or soon-to-be enrolling clinical trial, a victory against lung cancer, or their gratitude in the realm of lung cancer.

November is Lung Cancer Awareness Month. What are you grateful for?
November is Lung Cancer Awareness Month. What are you grateful for?
Photo by Gilles Frydman/Smart Patients

What we want to accomplish is threefold:

- First and foremost, we want more lung cancer patients talking to their doctors about clinical trials. GRACE’s team of faculty will highlight 15 trials that they think are the most exciting. 

- Secondly, we want to celebrate the moments of beauty that arise even during some of the toughest days of our lives. We asked doctors, patients, and caregivers to tell us, “In the world of lung cancer, what are you grateful for?” 

- Finally, we hope to give patients and caregivers a peek at the softer side of their medical teams. The doctors who participated in this initiative did so out of love, admiration and – yes – gratitude for their patients. 

And speaking of gratitude, I’d like to thank the doctors, patients, and caregivers who gave some pretty personal answers for our videos. Thank you to the doctors and researchers who are searching for answers through clinical trials. And thank you to Smart Patients, Celgene, Boehringer-Ingelheim, and Astra Zeneca for their support our gratitude campaign.

 

Next Previous link

Previous PostNext Post

Related Content

Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.  
Article
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Recent Comments

JOIN THE CONVERSATION
Yes, it's crucial to discuss…
By JanineT GRACE … on
Definitely a good idea to…
By OakleeFarnick on
Thank you for sharing
By LeviDrake on
Hi bluesun,I don't know of…
By JanineT GRACE … on